Pre-Test Combined Hormonal Contraceptives: A Focus on Recent Updates in Reproductive Care Pre-Test Which of the following statements regarding available combined hormonal contraceptives is TRUE? The pill and patch are self-administered by the patient, but the ring must be placed by a clinician each month The pill and ring contain estrogen components ≤35μg, but the patch contains higher levels of estrogen due to obstacles in transdermal drug delivery The pill is available in mono-or multi-phasic formulations, but the patch and ring are only available in fixed hormonal doses The patch provides less protection against pregnancy compared to the pill and ring but contains similar doses of estrogen and progestin Unsure Which of the following statements regarding the oral contraceptive containing drospirenone/estetrol is TRUE? The estetrol component is a commonly used synthetic estrogen The estetrol component is a form of estrogen mainly produced by the ovaries of adult women The estetrol component is a natural estrogen with selective action in tissues (NEST) The oral contraceptive contains 3mg drospirenone and 16.2mg estetrol Unsure How confident are you in discussing hormonal contraceptives with patients? Very confident Confident Somewhat confident Not very confident Not at all confident How often do you consider newer combined hormonal contraceptives and shared decision-making strategies to improve personalized reproductive healthcare and outcomes? Always Often Sometimes Rarely Never
